M Goiny, K Uvnäs-Moberg, S Cekan
Index: Psychopharmacology 89(1) , 108-12, (1986)
Full Text: HTML
IV injections of the dopamine receptor agonists bromocriptine (0.1 mg/kg) and apomorphine (0.05 mg/kg) induced rapid and long-lasting increases of cortisol levels as measured by RIA in peripheral venous plasma of conscious dogs. Pretreatment with dopamine receptor antagonists which do not readily penetrate the blood brain barrier (domperidone, halopemide, sulpiride) abolished the release responses induced by the dopamine agonists. These results suggest that the dopamine receptor agonists stimulate cortisol release at a site located outside the blood brain barrier. In addition, some dopamine receptor antagonists (haloperidol, chlorpromazine, milenperone) were shown to cause a rapid and long-lasting increase of cortisol levels.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
halopemide
CAS:59831-65-1 |
C21H22ClFN4O2 |
CAY10593 inhibits the human P2X7 receptor independently of p...
2013-12-01 [Purinergic Signal. 9(4) , 609-19, (2013)] |
Halopemide, a new psychotropic agent. Cerebral distribution ...
1985-02-22 [Pharm. Weekbl. Sci. 7(1) , 1-9, (1985)] |
Dynamic cation-exchange systems for the separation of drugs ...
[J. Chromatogr. A. 164(2) , 177-85, (1979)] |
Endocrine effects of domperidone: a peripheral dopamine bloc...
1981-09-01 [Clin. Endocrinol. (Oxf.) 15(3) , 275-82, (1981)] |
Effects of halopemide on potassium-induced release of radiol...
1980-09-01 [Arch. Int. Pharmacodyn. Ther. 247(1) , 43-58, (1980)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved